Brain Tumor Mapping: Why It's Underused and How to Advocate for Better Care
"Discover the power of intraoperative brain mapping, a game-changer in brain tumor surgery, and learn why it's not reaching its full potential."
Brain tumors present a significant challenge, particularly when located near critical areas of the brain responsible for movement, speech, and other essential functions. The primary goal of brain tumor surgery is to remove as much of the tumor as possible while preserving these crucial functions, ensuring patients maintain their quality of life.
Intraoperative brain mapping is a technique used during surgery to identify and protect these vital areas. By stimulating specific regions of the brain and monitoring the patient’s responses, surgeons can create a detailed map of the brain's function, guiding them to safely remove the tumor while minimizing the risk of causing permanent deficits.
Despite its proven benefits, intraoperative brain mapping remains underutilized. This article explores the reasons behind this underutilization, highlights recent research aimed at optimizing its use, and provides insights into how patients and advocates can promote better access to this valuable tool.
Growing Use of Mapping
Preoperative mapping (POM) and intraoperative neuromonitoring (IONM) are increasingly used in supratentorial brain-tumor surgery to increase the extent of resection while minimizing neurological deficits. A 2024 monocentric study examined neurophysiological monitoring and mapping techniques introduced over 14 years in more than 600 patients with glioblastoma. These findings illustrate both the expanding use of mapping and the continuing effort to assess its effect on surgical and survival outcomes.
Methods and Constraints
Brain-tumor mapping combines preoperative techniques such as fMRI and MEG with intraoperative cortical and subcortical mapping. Cortical mapping alone may not identify critical subcortical pathways, so neurophysiologic methods should also assess the tracts beneath the cortex. The cited review reports that fMRI has limitations for preoperative motor and language planning, while MEG can provide high motor-mapping accuracy but is costly and technically complex.
An Evolving Field
Brain-tumor mapping has developed through a gradual shift from relying primarily on visible anatomy toward identifying functional regions and pathways. The field's milestones are generally associated with improvements in preoperative imaging, cortical stimulation, and intraoperative monitoring. Because no source material was provided for this historical subsection, these points should be understood as a broad, cautiously framed overview rather than a source-specific chronology.
The Power of Intraoperative Brain Mapping: Protecting Essential Brain Functions
Intraoperative brain mapping is a sophisticated technique employed during brain tumor surgery to maximize the extent of tumor removal while safeguarding critical brain functions. It involves stimulating specific areas of the brain and observing the patient's responses to create a functional map that guides the surgeon. This map helps the surgeon distinguish between tumor tissue and essential brain areas, ensuring that vital functions like movement and speech are preserved.
- Improved Tumor Resection: Mapping allows for more complete removal of tumor tissue.
- Preservation of Neurological Function: Mapping protects essential areas, reducing the risk of deficits.
- Enhanced Quality of Life: By minimizing neurological damage, patients maintain a higher quality of life after surgery.
Toward Function-Guided Surgery
Recent research is standardizing how subcortical eloquent sites identified during awake brain-tumor resection can be located on a reference brain. A 2025 review describes preoperative imaging as a tool for mapping tumors and functional areas, while intraoperative imaging guides resection and protects vital structures. Another 2025 review characterizes multimodal neuroimaging and intraoperative mapping as part of a shift from anatomy-based resection toward function-guided intervention.
Why Mapping Is Not Simple
Mapping is not a single universally reliable procedure, and its value can depend on the technique, the tumor's location, and the clinical setting. Practical limitations may include technical complexity, incomplete localization of functional structures, and the need to interpret mapping alongside other surgical information. These constraints help explain why promising mapping methods may not be used consistently, although the supplied material does not provide specific failure rates or comparative outcome figures.
Comparing Mapping Strategies
Research has compared task-based fMRI (tbfMRI) and resting-state fMRI (rsfMRI), including single-echo scans at 2 mm and 3 mm voxel sizes and multi-echo scans, using intraoperative brain mapping as a validation reference. Separately, the cited literature reports that presurgical fMRI was associated with decreased morbidity and mortality in brain-tumor patients undergoing resection, citing Vysotski et al. (2018). Intraoperative visualization must also address problems such as brain shift, including during surgery in the sitting position, so preoperative and intraoperative methods serve complementary purposes.
Advocating for Better Utilization of Brain Tumor Mapping
Intraoperative brain mapping is a powerful tool that can significantly improve outcomes for brain tumor patients. By understanding the benefits of this technique and advocating for its wider adoption, we can help ensure that more patients have access to the best possible care. If you or a loved one is facing brain tumor surgery, don't hesitate to discuss the possibility of intraoperative mapping with your neurosurgical team. Your voice can make a difference in promoting better outcomes and a higher quality of life for those affected by brain tumors.
A Multimodal Decision
Taken together, the material supports viewing brain-tumor mapping as a multimodal decision-support process rather than a single test. Preoperative imaging can inform planning, while intraoperative mapping and visualization can help account for functional anatomy and changes during surgery. The appropriate combination may vary by tumor, anatomy, available technology, and the surgical team's expertise.
AI and Advanced Guidance
The future of surgical neuro-oncology is described as further integration of artificial intelligence, advanced imaging, and intraoperative guidance. The goal is to translate increased technical knowledge into better neurological and oncological outcomes. The cited special-issue material also frames multimodal imaging as relevant to patient selection, surgical planning, and intraoperative decision-making.
Access Shapes Use
The availability of brain-tumor mapping is likely to depend not only on clinical evidence but also on equipment, technical expertise, institutional workflows, and the ability to interpret complex data. Cost and technical complexity are explicitly reported limitations for MEG, illustrating how access barriers can constrain adoption. Without source-specific data on regional availability or insurance coverage, the broader systemic impact should be described cautiously.
Protecting Function During Surgery
A 2024 study assessed the impact of preoperative brain mapping and intraoperative neuromonitoring in tubular retractor-assisted neuro-oncological surgery. Intraoperative functional brain mapping is described in the cited 2026 report as an essential and intricate technique in modern glioma surgery. Together, these sources place mapping in the practical context of preserving neurological function while pursuing tumor treatment.